OmniStar Financial Group’s GSK GSK Stock Holding History

OmniStar Financial Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,595	Closed	-$577K	–	135
2021 Q2	$577K	Buy	+11,595	New	+$557K	0.71%	56

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OmniStar Financial Group's GSK Position: Q1 2024 in Review

OmniStar Financial Group sold out of GSK (GSK) in Q1 2024, closing a stake of 15,778 shares — an estimated $585K sold.

OmniStar Financial Group first reported a position in GSK in Q4 2017 and held it in 22 quarters. The position peaked at $1.47M in Q4 2019. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

OmniStar Financial Group reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
OmniStar Financial Group sold 15,778 GSK shares in Q1 2024, an estimated $585K.
OmniStar Financial Group first reported a position in GSK in Q4 2017 and held it in 22 quarters.
OmniStar Financial Group's GSK position peaked at $1.47M in Q4 2019.
910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on OmniStar Financial Group's 13F filing for Q1 2024, filed 23 Apr 2024.